Impella Pump Improves Survival in STEMI-Related Cardiogenic Shock
First trial in a quarter-century to show mortality benefit in this desperately ill group
Stay updated with breaking news from Odense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First trial in a quarter-century to show mortality benefit in this desperately ill group
A retrospective study found a sex difference in patients with aortic stenosis treated with ARBs.
Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to a study presented at the American College of Cardiology's Annual Scientific Session.
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
Are you planning to explore more of the U.S.A. this year or in the future? While you may have many famous and popular destinations and sites on your list,